Clinical Trial: Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Proprietary Information - Exploratory (Non-Confirmatory) Trial

Brief Summary:

This study is to evaluate an investigational vaccine with the following objectives: (1) To demonstrate prevention of cervical, vulvar, and vaginal cancers and related precancers, external genital lesions, and persistent infection caused by the HPV types in the study vaccine, (2) To demonstrate that the vaccine is well-tolerated in women, (3) To evaluate vaccine immune responses in women.

This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome: Proprietary Information - Exploratory (Non-Confirmatory) Trial

Original Primary Outcome: Same as current

Current Secondary Outcome: Proprietary Information - Exploratory (Non-Confirmatory) Trial

Original Secondary Outcome: Same as current

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: August 16, 2006
Date Started: October 2006
Date Completion:
Last Updated: June 18, 2015
Last Verified: June 2015